Courtney Miller

Development of Therapeutic candidates for stimulant use disorder using AI-driven platform for focused drug discovery and accelerated development

Exploring synaptic actin-myosin dynamics with super resolution microscopy

BioRaptr Replacement Dispensers to Support High Throughput Screening

Preclinical development of a precision therapy for a monogenic mental health disorder

REU Site: SURFing the Interface between Chemistry and Biology

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

The Impact of Individual Vulnerability to Stress on Alcohol and Drug Seeking

Intersection of causal neurodevelopmental disorder risk genes, cortical circuit function, and cognitive processing required for behavioral adaptions

Targeting Go and Grow in Glioblastoma

Development of AI-driven model for anti-SUD drug development based on neuronal plasticity

Neurodevelopmental Disorder Risk Gene Regulation of Intrinsic Membrane Excitability: A Rheostat that Tunes Dendritic Morphogenesis to Regulate Circuit Assembly During Development

Assessing the role of circRNAs in memory consolidation

Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma

REU Site: SURFing the Interface between Chemistry and Biology

Circuit-level substrates of ASD-related cognitive and behavioral impairments

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

Preventing alcohol seeking with a nonmuscle myosin II inhibitor under clinical development

Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related Disorders

Myosin II regulation of actin dynamics and the selective vulnerability of methamphetamine- and opioid-associated memory